Interplay between metabolism and transport of resveratrol (Q38121602)

29 August 2017

Interplay between metabolism and transport of resveratrol (English)

1 reference

29 August 2017

5

1 reference

29 August 2017

Alexandra Maier-Salamon

1

1 reference

29 August 2017

Michaela Böhmdorfer

2

1 reference

29 August 2017

Juliane Riha

3

1 reference

29 August 2017

Theresia Thalhammer

4

1 reference

29 August 2017

Walter Jaeger

6

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

Annals of the New York Academy of Sciences

29 August 2017

1 reference

29 August 2017

1290

1 reference

29 August 2017

98-106

1 reference

One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.

29 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Resveratrol has anti-leukemic activity associated with decreased O-GlcNAcylated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

trans-Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Anti-estrogenic activity of a human resveratrol metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Resveratrol 3-O-D-glucuronide and resveratrol 4'-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Hepatic metabolism and biliary excretion of valerenic acid in isolated perfused rat livers: role of Mrp2 (Abcc2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Metabolites and tissue distribution of resveratrol in the pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

Hepatic Glucuronidation of Resveratrol: Interspecies Comparison of Enzyme Kinetic Profiles in Human, Mouse, Rat, and Dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12198

21 January 2018

Identifiers

DOI

10.1111/NYAS.12198

1 reference

29 August 2017

1 reference